04:48 PM EST, 01/08/2025 (MT Newswires) -- Christopher Peetz, Director, CEO, on January 07, 2025, sold 7,489 shares in Mirum Pharmaceuticals ( MIRM ) for $320,644. Following the Form 4 filing with the SEC, Peetz has control over a total of 327,929 shares of the company, with 119,359 shares held directly and 208,570 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1759425/000141588925001143/xslF345X05/form4-01082025_090146.xml